Skip to main content

Advertisement

Table 3 Binary outcome measures

From: Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis

  Rivaroxaban only (n = 52) Rivaroxaban + IA TXA (n = 52) p-value
Transfusionsa 26 (50.0%) 8 (15.4%) < 0.001
Ultrasound-diagnosed DVTb 2 (3.8%) 3 (5.8%) 1.000
Wound complicationsb 6 (11.5%) 0 (0%) 0.027
  1. All values presented as the number of patients (percentage)
  2. aCompared using Pearson’s chi-square test
  3. bCompared using Fisher’s exact test